Page last updated: 2024-11-11

bialaphos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bilanafos : A tripeptide comprising one L-phosphinothricyl and two L-alanyl units joined in sequence. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5462314
CHEBI ID3088
SCHEMBL ID18706
MeSH IDM0044088

Synonyms (34)

Synonym
phosphinothricylalanylalanine
l-alanine, 4-(hydroxymethylphosphinyl)-l-2-aminobutanoyl-l-alanyl-
antibiotic sf 1293
bilanafos [iso]
l-alanine, gamma-(hydroxymethylphosphinyl)-l-alpha-aminobutyryl-l-alanyl-
bialaphos
2-amino-4-(methylphosphino)butyrylalanylalanine
35597-43-4
gamma-(hydroxymethylphosphinyl)-l-alpha-aminobutyryl-l-alanyl-l-alanine
bilanafos
C06457
phosphinothricin tripeptide
PTT ,
(2s)-2-amino-4-(hydroxymethylphosphinyl)butanoyl-l-alanyl-l-alanine
(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]propanoic acid
7488pcm6i2 ,
unii-7488pcm6i2
phosphinothricyl-alanyl-alanine
herby
bilanaphos
phosphinothricin-alanyl-alanine
antibiotic sf-1293
bilanafos (salt)
SCHEMBL18706
DTXSID5058066
n-{(2s)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoyl}-l-alanyl-l-alanine
CHEBI:3088
(2s)-2-amino-4-[hydroxy(methyl)phosphinoyl]butyryl-l-alanyl-l-alanine
l-phosphinothricyl-l-alanyl-l-alanine
Q855280
(2s)-2-[[(2r)-2-[[(2s)-2-amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]propanoic acid
bialaphos (sodium salt?)
l-alanine, n-[(2s)-2-amino-4-(hydroxymethylphosphinyl)-1-oxobutyl]-l-alanyl-
AKOS040744528
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tripeptideAny oligopeptide that consists of three amino-acid residues connected by peptide linkages.
phosphinic acids
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (97)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (16.49)18.7374
1990's43 (44.33)18.2507
2000's23 (23.71)29.6817
2010's13 (13.40)24.3611
2020's2 (2.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.71 (24.57)
Research Supply Index4.60 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index45.89 (26.88)
Search Engine Supply Index2.09 (0.95)

This Compound (33.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.03%)5.53%
Reviews6 (6.19%)6.00%
Case Studies3 (3.09%)4.05%
Observational0 (0.00%)0.25%
Other87 (89.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]